RM-853

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameRM-853
Drug Alias NameRM-853T3525770
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGhrelin O-acyltransferase inhibitors
TargetsGhrelin O-acyltransferase
Therapy Area/IndicationsPrader-Willi Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdRhythm Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPrader-Willi Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A